title: A single center experience with basiliximab induction therapy in renal transplantation.
authors.affiliation: The Ohio State University Medical Center, Department of Surgery, Division of Transplantation, Columbus, Ohio 43210, USA.
authors.forename: M L
authors.initials: ML
authors.lastname: Henry
authors.forename: R P
authors.initials: RP
authors.lastname: Pelletier
authors.forename: E A
authors.initials: EA
authors.lastname: Elkhammas
authors.forename: G L
authors.initials: GL
authors.lastname: Bumgardner
authors.forename: R M
authors.initials: RM
authors.lastname: Ferguson
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000077552:Basiliximab; D002102:Cadaver; D002648:Child; D005190:Family; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D011993:Recombinant Fusion Proteins; D012189:Retrospective Studies; D014019:Tissue Donors / Q000706:statistics & numerical data; D014184:Transplantation, Homologous; D044465:White People
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab